3 Motors and Generators Maker, IT Services Company and Global Pharmaceutical Company Stocks With a Strong Future Roadmap: Kirloskar Electric Company, Mindteck (India) and Cipla
- November 6, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Kirloskar Electric Company, Mindteck (India) and Cipla: ROE of 10.4% to 12.3% and FY22 to FY26 revenue CAGR of 7.1% to 8.3%. Prices as of 5 Nov 2026.
Quick Answer
The three electric motor, IT services and pharma stocks to watch are Kirloskar Electric Company, Mindteck (India) and Cipla. Their return on equity ranges from 10.4% to 12.3%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.1% to 8.3%. Kirloskar Electric Company has the highest return on equity at 12.3%, while Mindteck (India) has the fastest revenue growth at 8.3% a year. Prices are based on the 5 November 2026 close, and this article is educational, not investment advice.
Electric motor, IT services and pharma stocks let investors follow companies that serve a growing part of the Indian economy. Kirloskar Electric Company, Mindteck (India) and Cipla cover a motors and generators maker, an IT services company and a global pharmaceutical company.
This list covers three electric motor, IT services and pharma stocks with complete current figures: Kirloskar Electric Company, Mindteck (India) and Cipla. Every figure comes from the latest reported financials and the 5 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Electric Motor, IT Services and Pharma Stocks?
Electric motor, IT services and pharma stocks are listed companies that make electric motors, generators and transformers, provide technology and engineering services, and develop and sell medicines including respiratory therapies. Their earnings depend on power equipment orders, client technology budgets and prescription demand.
Electric Motor, IT Services and Pharma Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Kirloskar Electric Company | 108.82 | 811 | 108.5 | 43.9 | 12.3 | 0.76 |
| Mindteck (India) | 135.52 | 436 | 14.0 | 17.6 | 10.4 | 0.01 |
| Cipla | 1,404.1 | 107,528 | 32.0 | 36.0 | 11.3 | 0.02 |
On valuation, Mindteck (India) and Cipla trade at a P/E below the industry P/E, while Kirloskar Electric Company trades above it, which reflects the growth the market already expects. Readers comparing electric motor, IT services and pharma stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Electric Motor, IT Services and Pharma Stocks Have a Strong Roadmap in India?
Electric motor, IT services and pharma stocks have a strong roadmap in India because rising power infrastructure investment, growing outsourcing of technology work and steady global demand for medicines keep widening the market for these companies.
- Electrical machines. Grids and factories need motors and generators.
- IT services. Global clients outsource engineering work.
- Pharma. Patients need dependable medicines.
Why Kirloskar Electric Company Features Among These Electric Motor, IT Services and Pharma Stocks
Among the electric motor, IT services and pharma stocks on this list, Kirloskar Electric Company is a Bengaluru-based maker of electric motors, alternators, generators, transformers and related electrical equipment for industry, railways and power customers.
Revenue rose from Rs 454 crore in FY22 to Rs 600 crore in FY26, a compound annual growth rate of 7.3%. Net profit grew from Rs 3.7 crore in FY25 to Rs 8.4 crore in FY26, a rise of 124.7%.
The company has a return on equity of 12.3%, a debt to equity ratio of 0.76 and a market capitalisation of Rs 811 crore. The stock trades at a P/E of 108.5, above the industry P/E of 43.9.
Roadmap: The company is widening its range of motors and generators and growing its supply for industrial, railway and power projects. Long industry experience and a wide product range support its order book.
What to watch: Track order inflows, execution and demand from power and railway customers.
Why Mindteck (India) Features Among These Electric Motor, IT Services and Pharma Stocks
Among the industrial drive, technology and medicine shares on this list, Mindteck (India) provides IT services including software development, data and analytics and cloud support to clients across healthcare, financial services and other industries.
The company has a return on equity of 10.4%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 436 crore. The stock trades at a P/E of 14.0, below the industry P/E of 17.6.
Revenue rose from Rs 304 crore in FY22 to Rs 417 crore in FY26, a compound annual growth rate of 8.3%. Net profit grew from Rs 20.8 crore in FY23 to Rs 31.5 crore in FY26, which works out to a compound annual growth rate of 14.9%. In the June 2026 quarter, revenue grew 2.8% year on year to Rs 107 crore.
Roadmap: The company is focusing on digital engineering, data and cloud services for existing clients and widening its work in specialised industries. Long client relationships support steady project flow.
What to watch: Monitor client additions, utilisation and currency movements.
Why Cipla Features Among These Electric Motor, IT Services and Pharma Stocks
Among the three companies on this list, Cipla is a Mumbai-based pharmaceutical company with strengths in respiratory medicines, anti-infectives and chronic therapies. It sells branded and generic products in India, South Africa, the United States and other markets.
Revenue rose from Rs 22,044 crore in FY22 to Rs 29,045 crore in FY26, a compound annual growth rate of 7.1%. Net profit grew from Rs 2,559 crore in FY22 to Rs 3,870 crore in FY26, which works out to a compound annual growth rate of 10.9%.
In the June 2026 quarter, revenue grew 1.6% year on year to Rs 7,330 crore. The company has a return on equity of 11.3%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 107,528 crore. The stock trades at a P/E of 32.0, below the industry P/E of 36.0.
Roadmap: The company is deepening its position in respiratory and complex generic products while expanding its consumer health and domestic prescription brands. A wide global footprint spreads its earnings across several markets.
What to watch: Follow new product launches in the United States and the growth of key domestic brands.
Kirloskar Electric Company vs Mindteck (India) vs Cipla on Key Financials
The table below sets the three electric motor, IT services and pharma stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Kirloskar Electric Company | 454 | 600 | 7.3% | 8.4 | 1.4% |
| Mindteck (India) | 304 | 417 | 8.3% | 31.5 | 7.6% |
| Cipla | 22,044 | 29,045 | 7.1% | 3,870 | 13.3% |
Kirloskar Electric Company posts the highest return on equity in this group at 12.3%. Cipla has the largest FY26 revenue at Rs 29,045 crore, and Mindteck (India) shows the fastest revenue growth with a 8.3% compound annual rate. A useful habit with electric motor, IT services and pharma stocks is to check each new quarterly result against the capacity plans the company described earlier.
Key Risks to Check Before Investing in Electric Motor, IT Services and Pharma Stocks
Every theme carries risks that deserve a check before any decision. For these electric motor, IT services and pharma stocks, the main points are: Long-term industrial drive, technology and medicine shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Component costs. Copper, chips and other inputs can move margins.
- Client spending. Technology budgets can vary with global conditions.
- Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter electric motor, IT services and pharma stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Electric Motor, IT Services and Pharma Stocks
Electric motor, IT services and pharma stocks reward investors who follow demand trends, order books and margins together. Kirloskar Electric Company, Mindteck (India) and Cipla each have a clear plan to grow. Based on the 5 November 2026 close, Kirloskar Electric Company trades at Rs 108.82, Mindteck (India) at Rs 135.52 and Cipla at Rs 1,404.1.
Download the Univest iOS App or Univest Android App to track electric motor, IT services and pharma stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are electric motor, IT services and pharma stocks?
Ans. Electric motor, IT services and pharma stocks are listed companies that make electric motors, generators and transformers, provide technology and engineering services, and develop and sell medicines including respiratory therapies. Their earnings depend on power equipment orders, client technology budgets and prescription demand. This list looks at three of them, Kirloskar Electric Company, Mindteck (India) and Cipla, using reported FY22 to FY26 financials and the 5 November 2026 closing prices.
Which electric motor, IT services and pharma stocks are covered in this list?
Ans. This list covers Kirloskar Electric Company, Mindteck (India) and Cipla. Based on the 5 November 2026 close, Kirloskar Electric Company traded at Rs 108.82, Mindteck (India) at Rs 135.52 and Cipla at Rs 1,404.1. Their return on equity ranges from 10.4% to 12.3%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.1% to 8.3%.
Why do electric motor, IT services and pharma stocks have a strong future roadmap in India?
Ans. Electric motor, IT services and pharma stocks have a strong roadmap in India because rising power infrastructure investment, growing outsourcing of technology work and steady global demand for medicines keep widening the market for these companies. The main drivers are as follows. Electrical machines. Grids and factories need motors and generators. IT services. Global clients outsource engineering work. Pharma. Patients need dependable medicines. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Kirloskar Electric Company performed financially?
Ans. Revenue rose from Rs 454 crore in FY22 to Rs 600 crore in FY26, a compound annual growth rate of 7.3%. Net profit grew from Rs 3.7 crore in FY25 to Rs 8.4 crore in FY26, a rise of 124.7%. The company has a return on equity of 12.3%, a debt to equity ratio of 0.76 and a market capitalisation of Rs 811 crore. The stock trades at a P/E of 108.5, above the industry P/E of 43.9. Looking ahead, the company is widening its range of motors and generators and growing its supply for industrial, railway and power projects. Long industry experience and a wide product range support its order book.
How has Mindteck (India) performed financially?
Ans. Revenue rose from Rs 304 crore in FY22 to Rs 417 crore in FY26, a compound annual growth rate of 8.3%. Net profit grew from Rs 20.8 crore in FY23 to Rs 31.5 crore in FY26, which works out to a compound annual growth rate of 14.9%. In the June 2026 quarter, revenue grew 2.8% year on year to Rs 107 crore. The company has a return on equity of 10.4%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 436 crore. The stock trades at a P/E of 14.0, below the industry P/E of 17.6. Looking ahead, the company is focusing on digital engineering, data and cloud services for existing clients and widening its work in specialised industries. Long client relationships support steady project flow.
How has Cipla performed financially?
Ans. Revenue rose from Rs 22,044 crore in FY22 to Rs 29,045 crore in FY26, a compound annual growth rate of 7.1%. Net profit grew from Rs 2,559 crore in FY22 to Rs 3,870 crore in FY26, which works out to a compound annual growth rate of 10.9%. In the June 2026 quarter, revenue grew 1.6% year on year to Rs 7,330 crore. The company has a return on equity of 11.3%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 107,528 crore. The stock trades at a P/E of 32.0, below the industry P/E of 36.0. Looking ahead, the company is deepening its position in respiratory and complex generic products while expanding its consumer health and domestic prescription brands. A wide global footprint spreads its earnings across several markets.
What risks should investors check before buying electric motor, IT services and pharma stocks?
Ans. Investors should check a few risks before buying electric motor, IT services and pharma stocks. Component costs. Copper, chips and other inputs can move margins. Client spending. Technology budgets can vary with global conditions. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of electric motor, IT services and pharma stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 5 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
